Literature DB >> 10800823

Incidence and implications of systemic to pulmonary collaterals after bidirectional cavopulmonary anastomosis.

D B McElhinney1, V M Reddy, W Tworetzky, E Petrossian, F L Hanley, P Moore.   

Abstract

BACKGROUND: Systemic to pulmonary arterial collaterals often develop after bidirectional cavopulmonary anastomosis (BCPA). It has been proposed that such collaterals may be related to perioperative outcome and duration of effusions after the modified Fontan procedure. However, the incidence and significance of collaterals after BCPA remain uncertain.
METHODS: To evaluate risk factors for, and significance of, such collaterals, we reviewed angiographic and clinical data for all 76 patients who underwent BCPA between January 1990 and June 1996 and had follow-up catheterization during or before 1997.
RESULTS: The median age at BCPA was 10 months, and the median duration from BCPA to follow-up catheterization was 18 months. Arterial collaterals were detected on follow-up catheterization in 45 patients (59%). Factors associated with collateral development included a prior right-sided systemic-to-pulmonary arterial shunt, lower pre-BCPA end-diastolic ventricular pressure and pulmonary vascular resistance, and use and duration of cardiopulmonary bypass during the BCPA operation. Fourteen of the 45 patients (30%) underwent coil embolization of the collaterals. Forty-three patients have undergone extracardiac conduit Fontan, with 1 early and 1 late death. Collaterals were present in 22 of these patients, 7 of whom underwent pre-Fontan embolization. The duration from BCPA to Fontan was longer in patients with collaterals, but these patients were not more likely to have prolonged effusions than those without, and the duration of tube thoracostomy was significantly shorter in patients with collaterals. Embolization of collaterals did not affect the duration of effusions.
CONCLUSIONS: Systemic-to-pulmonary arterial collaterals are common after BCPA. In contrast to prior reports, collaterals were not associated with a higher incidence of prolonged effusions after the Fontan procedure in our experience, and did not correlate with poor outcome.

Entities:  

Mesh:

Year:  2000        PMID: 10800823     DOI: 10.1016/s0003-4975(99)01088-7

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  24 in total

1.  The role of cardiovascular magnetic resonance in candidates for Fontan operation: proposal of a new algorithm.

Authors:  Lamia Ait-Ali; Daniele De Marchi; Massimo Lombardi; Luigi Scebba; Eugenio Picano; Bruno Murzi; Pierluigi Festa
Journal:  J Cardiovasc Magn Reson       Date:  2011-11-11       Impact factor: 5.364

2.  What is the clinical utility of routine cardiac catheterization before a Fontan operation?

Authors:  Puja Banka; Doff B McElhinney; Emile A Bacha; John E Mayer; Kimberlee Gauvreau; Tal Geva; David W Brown
Journal:  Pediatr Cardiol       Date:  2010-05-26       Impact factor: 1.655

3.  Advanced embolization techniques.

Authors:  K P Walsh
Journal:  Pediatr Cardiol       Date:  2005 May-Jun       Impact factor: 1.655

4.  Status of systemic to pulmonary arterial collateral flow after the fontan procedure.

Authors:  Kevin K Whitehead; Matthew A Harris; Andrew C Glatz; Matthew J Gillespie; Michael V DiMaria; Neil E Harrison; Yoav Dori; Marc S Keller; Jonathan J Rome; Mark A Fogel
Journal:  Am J Cardiol       Date:  2015-03-24       Impact factor: 2.778

5.  Practice variability and outcomes of coil embolization of aortopulmonary collaterals before Fontan completion: a report from the Pediatric Heart Network Fontan Cross-Sectional Study.

Authors:  Puja Banka; Lynn A Sleeper; Andrew M Atz; Collin G Cowley; Dianne Gallagher; Matthew J Gillespie; Eric M Graham; Renee Margossian; Brian W McCrindle; Charlie J Sang; Ismee A Williams; Jane W Newburger
Journal:  Am Heart J       Date:  2011-07       Impact factor: 4.749

6.  Ratio between fms-like tyrosine kinase 1 and placental growth factor in children with congenital heart disease.

Authors:  Masaya Sugimoto; Hideharu Oka; Aya Kajihama; Kouichi Nakau; Seiko Kuwata; Clara Kurishima; Hiroshi Azuma
Journal:  Pediatr Cardiol       Date:  2014-11-12       Impact factor: 1.655

Review 7.  Hypoplastic left heart syndrome: current considerations and expectations.

Authors:  Jeffrey A Feinstein; D Woodrow Benson; Anne M Dubin; Meryl S Cohen; Dawn M Maxey; William T Mahle; Elfriede Pahl; Juan Villafañe; Ami B Bhatt; Lynn F Peng; Beth Ann Johnson; Alison L Marsden; Curt J Daniels; Nancy A Rudd; Christopher A Caldarone; Kathleen A Mussatto; David L Morales; D Dunbar Ivy; J William Gaynor; James S Tweddell; Barbara J Deal; Anke K Furck; Geoffrey L Rosenthal; Richard G Ohye; Nancy S Ghanayem; John P Cheatham; Wayne Tworetzky; Gerard R Martin
Journal:  J Am Coll Cardiol       Date:  2012-01-03       Impact factor: 24.094

Review 8.  Current treatment and prognosis in children with functionally univentricular hearts.

Authors:  R Kaulitz; M Hofbeck
Journal:  Arch Dis Child       Date:  2005-07       Impact factor: 3.791

9.  Routine Cardiac Catheterization Prior to Fontan Operation: Is It a Necessity?

Authors:  Bassel Mohammad Nijres; Joshua J Murphy; Karim Diab; Sawsan Awad; Ra-Id Abdulla
Journal:  Pediatr Cardiol       Date:  2018-02-03       Impact factor: 1.655

10.  Characterizing the angiogenic activity of patients with single ventricle physiology and aortopulmonary collateral vessels.

Authors:  Nefthi Sandeep; Yutaka Uchida; Kanishka Ratnayaka; Robert McCarter; Sridhar Hanumanthaiah; Aminata Bangoura; Zhen Zhao; Jacqueline Oliver-Danna; Linda Leatherbury; Joshua Kanter; Yoh-Suke Mukouyama
Journal:  J Thorac Cardiovasc Surg       Date:  2015-10-09       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.